Multiple adjusted logistic regression model predicting postpartum glucose screening among women with history of GDM: the KPNC GDM registry: 1995–2006
| . | Odds ratio (95% CI) . |
|---|---|
| Age (years) | |
| <25 | 1.00 |
| 25–35 | 1.43 (1.23–1.67) |
| ≥36 | 1.80 (1.52–2.14) |
| Race | |
| Non-Hispanic white | 1.00 |
| African American | 0.86 (0.70–1.05) |
| Asian | 1.36 (1.23–1.51) |
| Hispanic | 1.37 (1.23–1.52) |
| Other/missing | 1.10 (0.96–1.27) |
| Education | |
| Less than high school | 1.02 (0.87–1.19) |
| High school graduate | 1.00 |
| 2-year college | 1.03 (0.91–1.17) |
| 4-year college | 1.22 (1.08–1.38) |
| Postgraduate education | 1.21 (1.04–1.40) |
| Parity | |
| 0 | 1.00 |
| 1 | 0.93 (0.84–1.03) |
| ≥2 | 0.82 (0.74–0.92) |
| Income | |
| <$30,000 | 1.00 |
| $30,000–59,000 | 1.04 (0.87–1.24) |
| $60,000–99,000 | 1.07 (0.89–1.28) |
| ≥$100,000 | 1.24 (0.98–1.57) |
| Obese | |
| No | 1.00 |
| Yes | 0.73 (0.63–0.86) |
| Gestational age at diagnosis of GDM (weeks) | |
| <20 | 1.00 |
| 20–24 | 0.89 (0.72–1.09) |
| 25–30 | 0.90 (0.79–1.02) |
| 31–37 | 0.55 (0.47–0.63) |
| ≥38 | 0.30 (0.14–0.62) |
| Insulin use during pregnancy | 1.51 (1.35–1.69) |
| Glyburide use during pregnancy | 1.27 (1.12–1.45) |
| Macrosomic infant delivered | |
| No | 1.00 |
| Yes | 1.01 (0.90–1.12) |
| Postpartum visits | |
| 0 visits | 1.00 |
| 1 visit | 2.48 (1.95–3.16) |
| ≥2 visits | 4.85 (3.86–6.10) |
| . | Odds ratio (95% CI) . |
|---|---|
| Age (years) | |
| <25 | 1.00 |
| 25–35 | 1.43 (1.23–1.67) |
| ≥36 | 1.80 (1.52–2.14) |
| Race | |
| Non-Hispanic white | 1.00 |
| African American | 0.86 (0.70–1.05) |
| Asian | 1.36 (1.23–1.51) |
| Hispanic | 1.37 (1.23–1.52) |
| Other/missing | 1.10 (0.96–1.27) |
| Education | |
| Less than high school | 1.02 (0.87–1.19) |
| High school graduate | 1.00 |
| 2-year college | 1.03 (0.91–1.17) |
| 4-year college | 1.22 (1.08–1.38) |
| Postgraduate education | 1.21 (1.04–1.40) |
| Parity | |
| 0 | 1.00 |
| 1 | 0.93 (0.84–1.03) |
| ≥2 | 0.82 (0.74–0.92) |
| Income | |
| <$30,000 | 1.00 |
| $30,000–59,000 | 1.04 (0.87–1.24) |
| $60,000–99,000 | 1.07 (0.89–1.28) |
| ≥$100,000 | 1.24 (0.98–1.57) |
| Obese | |
| No | 1.00 |
| Yes | 0.73 (0.63–0.86) |
| Gestational age at diagnosis of GDM (weeks) | |
| <20 | 1.00 |
| 20–24 | 0.89 (0.72–1.09) |
| 25–30 | 0.90 (0.79–1.02) |
| 31–37 | 0.55 (0.47–0.63) |
| ≥38 | 0.30 (0.14–0.62) |
| Insulin use during pregnancy | 1.51 (1.35–1.69) |
| Glyburide use during pregnancy | 1.27 (1.12–1.45) |
| Macrosomic infant delivered | |
| No | 1.00 |
| Yes | 1.01 (0.90–1.12) |
| Postpartum visits | |
| 0 visits | 1.00 |
| 1 visit | 2.48 (1.95–3.16) |
| ≥2 visits | 4.85 (3.86–6.10) |